TY - JOUR
T1 - Rheumatic heart disease in Timor-Leste school students
T2 - An echocardiography-based prevalence study
AU - Davis, Kimberly
AU - Remenyi, Bo
AU - Draper, Anthony D.K.
AU - Dos Santos, Januario
AU - Bayley, Noel
AU - Paratz, Elizabeth
AU - Reeves, Benjamin
AU - Appelbe, Alan
AU - Cochrane, Andrew
AU - Johnson, Timothy D.
AU - Korte, Laura M.
AU - Do Rosario, Ivonia M.
AU - Da Silva Almeida, Inez T.
AU - Roberts, Kathryn V.
AU - Carapetis, Jonathan R.
AU - Francis, Joshua R.
PY - 2018/4/16
Y1 - 2018/4/16
N2 - Objectives: To determine the prevalence of rheumatic heart disease (RHD) in school-aged children and young people in Timor-Leste. Design: Prospective cross-sectional survey. Echocardiography was performed by Australian cardiologists to determine the presence of RHD. Demographic data were also collected. Patients in whom RHD was detected were entered into a register to allow monitoring of adherence to secondary prophylaxis; the first dose of benzathine penicillin G (BPG) was administered on the day of screening. Setting: Schools in urban (Dili) and rural (Ermera) Timor-Leste. Participants: School students aged 5-20 years. Outcome measures: Definite and borderline RHD, as defined by World Heart Federation echocardiographic criteria. Results: 1365 participants were screened; their median age was 11 years (IQR, 9–14 years), and 53% were girls. The estimated prevalence of definite RHD was 18.3 cases per 1000 population (95% CI, 12.3–27.0 per 1000), and of definite or borderline RHD 35.2 per 1000 (95% CI, 26.5–46.4 per 1000). Definite (adjusted odds ratio [aOR], 3.5; 95% CI, 1.3–9.4) and definite or borderline RHD (aOR, 2.7; 95% CI, 1.4–5.2) were more prevalent among girls than boys. Eleven children (0.8%) had congenital heart disease. Of the 25 children in whom definite RHD was identified, 21 (84%) received education and a first dose of BPG on the day of screening; all 25 have since received education about primary care for RHD and have commenced penicillin prophylaxis. Conclusions: The rates of RHD in Timor-Leste are among the highest in the world, and prevalence is higher among girls than boys. Community engagement is essential for ensuring follow-up and the effective delivery of secondary prophylaxis.
AB - Objectives: To determine the prevalence of rheumatic heart disease (RHD) in school-aged children and young people in Timor-Leste. Design: Prospective cross-sectional survey. Echocardiography was performed by Australian cardiologists to determine the presence of RHD. Demographic data were also collected. Patients in whom RHD was detected were entered into a register to allow monitoring of adherence to secondary prophylaxis; the first dose of benzathine penicillin G (BPG) was administered on the day of screening. Setting: Schools in urban (Dili) and rural (Ermera) Timor-Leste. Participants: School students aged 5-20 years. Outcome measures: Definite and borderline RHD, as defined by World Heart Federation echocardiographic criteria. Results: 1365 participants were screened; their median age was 11 years (IQR, 9–14 years), and 53% were girls. The estimated prevalence of definite RHD was 18.3 cases per 1000 population (95% CI, 12.3–27.0 per 1000), and of definite or borderline RHD 35.2 per 1000 (95% CI, 26.5–46.4 per 1000). Definite (adjusted odds ratio [aOR], 3.5; 95% CI, 1.3–9.4) and definite or borderline RHD (aOR, 2.7; 95% CI, 1.4–5.2) were more prevalent among girls than boys. Eleven children (0.8%) had congenital heart disease. Of the 25 children in whom definite RHD was identified, 21 (84%) received education and a first dose of BPG on the day of screening; all 25 have since received education about primary care for RHD and have commenced penicillin prophylaxis. Conclusions: The rates of RHD in Timor-Leste are among the highest in the world, and prevalence is higher among girls than boys. Community engagement is essential for ensuring follow-up and the effective delivery of secondary prophylaxis.
UR - http://www.scopus.com/inward/record.url?scp=85046281955&partnerID=8YFLogxK
U2 - 10.5694/mja17.00666
DO - 10.5694/mja17.00666
M3 - Article
AN - SCOPUS:85046281955
SN - 0025-729X
VL - 208
SP - 303
EP - 307
JO - Medical Journal of Australia
JF - Medical Journal of Australia
IS - 7
ER -